RICK shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemRICK shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-37389-SH
Quantity20 µg
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Namereceptor interacting serine/threonine kinase 2
NCBI Gene AliasesCARD3, CARDIAK, CCK, GIG30, RICK, RIP2
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) XIAP down-regulation inhibits RIPK2 ubiquitination-mediated insulin resistanceEndocr ConnectDecember 16, 2025Chunnan Zhao, Zezhi Zhang, Ran Li, Xueli Gengvector/RIPK2 plasmid/XIAP plasmid for 48 h. The shRIPK2 plasmid was purchased from Santa Cruz Biotechnology (sc-37389-SH, China), with the shNC control plasmid included as a complimentary gift. RIPK2 plasmid (RR216875) and

(2) XIAP down-regulation inhibits RIPK2 ubiquitination-mediated insulin resistanceEndocr ConnectDecember 16, 2025Chunnan Zhao, Zezhi Zhang, Ran Li, Xueli Gengvector/RIPK2 plasmid/XIAP plasmid for 48 h. The shRIPK2 plasmid was purchased from Santa Cruz Biotechnology (sc-37389-SH, China), with the shNC control plasmid included as a complimentary gift. RIPK2 plasmid (RR216875) and

(3) Human procaspase-1 variants with decreased enzymatic activity are associated with febrile episodes and may contribute to inflammation via RIP2 and NF-κB signalingJournal of immunology (Baltimore, Md. : 1950)May 1, 2014Heymann MC, Winkler S, Luksch H, Flecks S, Franke M, Ruß S, Ozen S, Yilmaz E, Klein C, Kallinich T, et al.

(4) Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in human hepatoma cellsAnticancer researchSeptember 1, 2012Wu S, Kanda T, Nakamoto S, Imazeki F, Yokosuka O.

(5) Hepatitis B virus e antigen physically associates with receptor-interacting serine/threonine protein kinase 2 and regulates IL-6 gene expressionThe Journal of infectious diseasesAugust 1, 2012Wu S, Kanda T, Imazeki F, Nakamoto S, Tanaka T, Arai M, Roger T, Shirasawa H, Nomura F, Yokosuka O.

(6) GEF-H1 mediated control of NOD1 dependent NF-kappaB activation by Shigella effectorsPLoS pathogensNovember 1, 2008Fukazawa A, Alonso C, Kurachi K, Gupta S, Lesser CF, McCormick BA, Reinecker HC.

Be the First to Write a Review!